Chlamydia screening for profound immature women prevents baby complications, while saving health dollars

123 views Leave a comment

The investigate was published in BJOG: An International Journal of Obstetrics and Gynaecology (BJOG).

This University of Melbourne investigate is a initial Australian cost-effectiveness investigate to assistance remonstrate some-more clinicians to exercise chlamydia screening.  The investigate analysed a cost-effectiveness of chlamydia screening for all profound women between 16 and 25, compared with no screening during all, and resourceful screening for those during aloft risk of constrictive a infection.

They found that each chlamydia box rescued with a screening module as partial of their slight antenatal caring cost $1,641 to treat.

But this cost pales in comparison to treating complications of chlamydia such as handling a low birth weight baby (up to $6000), handling neonatal pneumonia (up to $3695) and handling pelvic inflammatory illness (up to $3636).

Chlamydia is one of a many common intimately transmitted infections in Australia, with superiority rates trimming from 3 per cent to 14 per cent among immature profound women (aged 16-25 years).

Chlamydia in pregnancy can lead to complications for mom and baby, including neonatal pneumonia, low birth weight, miscarriage and beforehand birth. However, many women knowledge no symptoms.

Screening can assistance to brand and provide a infection before complications develop. The Australian Government recommends chlamydia screening for all profound women aged 25 years aged and underneath during their initial antenatal visit. However a new consult of over 1600 Australian obstetricians and gynaecologists found that usually 21 per cent reported screening of all profound women aged underneath 25 during their antenatal visit.

When chlamydia superiority is 3 per cent, screening profound women between 16 and 25 is cost-effective.  If chlamydia superiority was aloft than 11 per cent, screening could outcome in cost assets to a Australian medical system.

Study co-author Doctor Jason Ong, from a University of Melbourne, pronounced a formula would be of seductiveness to other countries, quite a UK where slight screening is not conducted.

“Our investigate has shown a cost-effectiveness of slight chlamydia screening for profound women aged 16 to 25 years in Australia and will strengthen stream discipline and convince some-more medical professionals to exercise screening locally,” Dr Ong said.

“The advantage of incorporating chlamydia screening into antenatal care, means that chlamydia can be rescued and treated soon and there are no additional costs of attending another screening programme.”

Source: University of Melbourne